CORONA in the Saarland

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04837755

Acronym

CORSAAR

Enrollment

300

Registered

2021-04-08

Start date

2020-03-01

Completion date

2025-12-31

Last updated

2025-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19

Detailed description

Patients with all forms of COVID-19 are included and followed up. Medical history, measurements and biomarkers are registered and collected at baseline, dung hospitalization and after discharge. In addition, patients with LONG-COVID-19 are recruited.

Interventions

DIAGNOSTIC_TESTCytokine measurements

The serum concentrations of multiple cytokines are measured.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Years to 110 Years

Healthy volunteers

Inclusion criteria

all form of COVID-19 including long-COVID-19

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Correlation of biomarkers with mortality and disease subgroups	2 years after initial disease

Countries

Germany

Contacts

Primary ContactRobert Bals, MD PhD

robert.bals@uks.eu+4968411615051

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026